Apogee Reverses Lower Despite Promise For Twice-Yearly Eczema Shot

Why did Tesla stock drop after Musk’s political move? How will Trump’s tariff deadline impact global trade? What effects will OPEC+ output hike have on oil prices? Why is Nvidia expanding AI chip data centers in Europe? How did Texas flooding affect local businesses and markets? What are the implications of Trump's tax and spending bill? Why is Apple appealing a major EU antitrust fine?

Apogee Reverses Lower Despite Promise For Twice-Yearly Eczema Shot

investors.com/news/technology/apogee-therapeutics-eczema-shot

Apogee Therapeutics shares crumbled Monday despite promising results for what could become a quarterly or twice-yearly shot to control eczema.
The post Apogee Reverses Lower Despite Promise For Twice-Yearly Eczema Shot appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-07-07 14:08:23.